The prevalence, the incidence and the cost of COPD exacerbations

C. Janson (Uppsala, Sweden)

Source: Annual Congress 2011 - Epidemiology of COPD exacerbations
Session: Epidemiology of COPD exacerbations
Session type: Symposium
Number: 1863
Disease area: Airway diseases

Slide presentationMultimedia files

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Janson (Uppsala, Sweden). The prevalence, the incidence and the cost of COPD exacerbations. Annual Congress 2011 - Epidemiology of COPD exacerbations

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The costs of exacerbations in COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 273s
Year: 2001

Increasing risk of exacerbation and mortality associated with increasing frequency and severity of exacerbations in COPD patients: EXACOS-UK
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021


COPD mortality after severe exacerbations
Source: Virtual Congress 2020 – Monitoring of patients with COPD
Year: 2020


Trends in the lifetime risk of COPD exacerbation requiring hospitalisation
Source: Eur Respir J 2013; 42: 964-971
Year: 2013



In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality
Source: International Congress 2015 – COPD: interesting notes
Year: 2015

The prevalence of co-morbidities and exacerbations in COPD patients in Slovenia
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015


β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011

COPD patients with asthma, characteristics and risk of exacerbations
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019

Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study
Source: Eur Respir J 2011; 39: 38-45
Year: 2012



Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study
Source: Eur Respir J 2012; 39: 38-45
Year: 2012



The impact of weekends on outcome for acute exacerbations of COPD
Source: Eur Respir J 2012; 39: 46-50
Year: 2012



The impact of weekends on outcome for acute exacerbations of COPD
Source: Eur Respir J 2011; 39: 46-50
Year: 2012



A global survey conducted to determine frequency of exacerbations in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013


Early readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is associated with high mortality
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013


Survival in COPD patients with hospitalization due to exacerbation
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014


Acute exacerbations of COPD: The influence of comorbidities and chronic medication on mortality and exacerbation rate
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015


Glitazones are associated with reduced risk of COPD exacerbations and mortality among patients with diabetes
Source: Annual Congress 2011 - COPD: burden of disease, imaging and management
Year: 2011

The frequency of COPD exacerbations is related to the comorbidity profile
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016

Risk factors for another hospitalization in COPD patients hospitalized for exacerbation
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016


Characterization of readmissions in patients hospitalized with COPD exacerbation
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016